Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
3.915
+0.095 (2.49%)
Nov 4, 2024, 4:00 PM EST - Market closed
Arcadia Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 5 | 3 | 7 | 23 | 34 | 47 | |
Market Cap Growth | 16.42% | -47.96% | -71.05% | -32.20% | -28.18% | 213.03% | |
Enterprise Value | -2 | -11 | -14 | -8 | 34 | 19 | |
Last Close Price | 3.92 | 3.13 | 10.84 | 41.60 | 101.20 | 219.20 | |
PE Ratio | - | -0.28 | -0.42 | -1.51 | -5.41 | -1.21 | |
PS Ratio | 1.02 | 0.65 | 0.90 | 3.40 | 4.24 | 40.53 | |
PB Ratio | 0.46 | 0.27 | 0.32 | 0.74 | 1.19 | 5.69 | |
P/FCF Ratio | -0.34 | -0.23 | -0.48 | -0.86 | -1.05 | -2.54 | |
P/OCF Ratio | -0.34 | -0.23 | -0.48 | -0.89 | -1.13 | -2.76 | |
EV/Sales Ratio | -0.67 | -2.08 | -1.87 | -1.22 | 4.24 | 16.57 | |
EV/EBITDA Ratio | 0.27 | 0.84 | 1.01 | 0.36 | -2.06 | -0.97 | |
EV/EBIT Ratio | 0.26 | 0.83 | 0.98 | 0.34 | -1.98 | -0.96 | |
EV/FCF Ratio | 0.28 | 0.72 | 0.98 | 0.31 | -1.05 | -1.04 | |
Debt / Equity Ratio | 0.05 | 0.08 | 0.10 | 0.11 | 0.33 | 0.27 | |
Debt / FCF Ratio | -0.05 | -0.07 | -0.14 | -0.12 | -0.29 | -0.12 | |
Asset Turnover | 0.24 | 0.22 | 0.20 | 0.15 | 0.20 | 0.04 | |
Inventory Turnover | 2.00 | 1.98 | 1.93 | 2.18 | 3.16 | 7.78 | |
Quick Ratio | 3.32 | 3.39 | 5.19 | 5.96 | 4.29 | 4.54 | |
Current Ratio | 4.61 | 4.17 | 6.03 | 7.02 | 5.02 | 4.98 | |
Return on Equity (ROE) | -54.79% | -78.36% | -41.57% | -54.01% | -32.68% | -273.15% | |
Return on Assets (ROA) | -38.16% | -34.50% | -24.24% | -33.30% | -26.92% | -44.34% | |
Return on Capital (ROIC) | -53.68% | -45.80% | -30.76% | -41.98% | -44.39% | -107.34% | |
Earnings Yield | -127.11% | -402.29% | -230.24% | -63.54% | -13.68% | -60.79% | |
FCF Yield | -238.25% | -440.21% | -210.37% | -116.49% | -95.66% | -39.41% | |
Buyback Yield / Dilution | -55.17% | -106.37% | -12.66% | -113.68% | -56.51% | -68.94% | |
Total Shareholder Return | -55.17% | -106.37% | -12.66% | -113.68% | -56.51% | -68.94% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.